NCT05742711View on ClinicalTrials.gov

Efficacy of PENS of the Auricle as an Opioid Sparing Postoperative Analgesic Technique in Cancer Endometrium and Cancer Cervix Patients

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 16, 2023

Primary Completion Date

January 13, 2025

Study Completion Date

January 13, 2025

Conditions
Cancer of EndometriumCancer of Cervix
Interventions
DEVICE

Primary Relief

Continuous neurostimulation with a set of pre-assigned stimulation parameters.

DEVICE

Primary Relief - Sham Device

Standard treatment with the application of sham device shall be followed with additional analgesics available if necessary.

Trial Locations (1)

600020

Cancer Institute,(Wia), Chennai

Sponsors

Lead Sponsor

DyAnsys, Inc.
All Listed Sponsors
lead

DyAnsys, Inc.

INDUSTRY